ATM and melanoma: In a recent multicentric international study on 2105 melanoma cases, we associated germline heterozygous variants in ATM with melanoma risk, therefore proposing ATM, which was previously established as a melanoma genome-wide association study (GWAS) hit [5,6], as a melanoma intermediate-risk gene [7].